Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470

International Journal of Clinical Oncology

Volumn 6, Issue 5, 2001, Pages 215-220

  Saito, N ^a   Mitsuhashi, M ^a   Hayashi, T ^a   Narumo, C ^a   Nagata, H ^a   Soyama, K ^a   Kameoka, S ^a   Harumiya, S ^b   Fujimoto, D ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Angiogenesis; Cell binding domain; Colon cancer; Fibronectin; Metastasis; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; ARGINYLGLYCYLASPARTIC ACID; FIBRONECTIN; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CELL ADHESION; COLON CANCER; CONTROLLED STUDY; HISTOPATHOLOGY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TREATMENT OUTCOME;

EID: 0035193065     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012108     Document Type: Article

References (26)

1. Anti-angiogenesis: New concept for therapy of solid tumor
2. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
3. Angiogenesis
4. Domain structure of the carboxylterminal half of human plasma fibronectin
5. Human tissue fibronectin: Expression of different isotypes in the adult and fetal tissues
6. Potent antiangiogenic action of AGM-1470: Comparison to the fumagillin parent
7. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl) fumagillol (TNP-470; AGM-1470)
8. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice
9. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
10. Biochemical interactions of tumor cells with the basement membrane
11. Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model
12. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470
13. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
14. The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis
15. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470
16. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: Occurrence of apoptosis and necrosis
17. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin
18. Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats
19. AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle
20. In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor
21. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer
22. Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects
23. Laminin receptors and laminin-binding proteins during tumor invasion and metastasis: A review
24. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin
25. Inhibition of experimental metastasis of human fibrosarcoma cells by antirecombinant 37-kDa laminin binding protein antibody
26. Prevention of liver metastasis by cell-binding domain